vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
SYPRIS SOLUTIONS INC is the larger business by last-quarter revenue ($30.3M vs $21.2M, roughly 1.4× Autolus Therapeutics plc). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -373.3%, a 360.4% gap on every dollar of revenue. SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
AUTL vs SYPR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $30.3M |
| Net Profit | $-79.1M | $-3.9M |
| Gross Margin | — | 4.6% |
| Operating Margin | -337.9% | -10.9% |
| Net Margin | -373.3% | -12.9% |
| Revenue YoY | — | -9.5% |
| Net Profit YoY | 3.6% | -2992.6% |
| EPS (diluted) | $-0.30 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $30.3M | ||
| Q3 25 | $21.2M | $28.7M | ||
| Q2 25 | $20.9M | $31.4M | ||
| Q1 25 | $9.0M | $29.5M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | $0 | $35.7M | ||
| Q2 24 | $0 | $35.5M | ||
| Q1 24 | $10.1M | $35.6M |
| Q4 25 | — | $-3.9M | ||
| Q3 25 | $-79.1M | $517.0K | ||
| Q2 25 | $-47.9M | $-2.1M | ||
| Q1 25 | $-70.2M | $-899.0K | ||
| Q4 24 | — | $135.0K | ||
| Q3 24 | $-82.1M | $390.0K | ||
| Q2 24 | $-58.3M | $16.0K | ||
| Q1 24 | $-52.7M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 8.1% |
| Q4 25 | — | -10.9% | ||
| Q3 25 | -337.9% | -6.1% | ||
| Q2 25 | -292.6% | -4.6% | ||
| Q1 25 | -726.3% | -0.4% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 4.8% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | -384.1% | -3.9% |
| Q4 25 | — | -12.9% | ||
| Q3 25 | -373.3% | 1.8% | ||
| Q2 25 | -229.0% | -6.5% | ||
| Q1 25 | -781.1% | -3.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | -522.1% | -6.2% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.30 | $0.02 | ||
| Q2 25 | $-0.18 | $-0.09 | ||
| Q1 25 | $-0.26 | $-0.04 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-0.31 | $0.02 | ||
| Q2 24 | $-0.22 | $0.00 | ||
| Q1 24 | $-0.24 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $17.8M |
| Total Assets | $661.9M | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $17.8M | ||
| Q3 25 | $265.5M | $20.0M | ||
| Q2 25 | $346.5M | $18.7M | ||
| Q1 25 | $371.1M | $19.0M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | $477.0M | $18.2M | ||
| Q2 24 | $527.8M | $19.0M | ||
| Q1 24 | $582.0M | $20.8M |
| Q4 25 | — | $107.8M | ||
| Q3 25 | $661.9M | $112.5M | ||
| Q2 25 | $721.0M | $105.8M | ||
| Q1 25 | $746.3M | $110.2M | ||
| Q4 24 | — | $119.4M | ||
| Q3 24 | $827.5M | $121.6M | ||
| Q2 24 | $853.6M | $124.2M | ||
| Q1 24 | $901.4M | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-1.1M |
| Free Cash FlowOCF − Capex | $-72.3M | $-1.5M |
| FCF MarginFCF / Revenue | -341.2% | -5.0% |
| Capex IntensityCapex / Revenue | 20.8% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-67.9M | $-178.0K | ||
| Q2 25 | $-72.8M | $1.1M | ||
| Q1 25 | $-75.6M | $-5.5M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $-76.7M | $-4.8M | ||
| Q2 24 | $-51.1M | $6.2M | ||
| Q1 24 | $-40.5M | $-1.7M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-72.3M | $-390.0K | ||
| Q2 25 | $-80.1M | $941.0K | ||
| Q1 25 | $-83.8M | $-5.5M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-86.3M | $-4.9M | ||
| Q2 24 | $-51.9M | $6.0M | ||
| Q1 24 | $-41.0M | $-2.0M |
| Q4 25 | — | -5.0% | ||
| Q3 25 | -341.2% | -1.4% | ||
| Q2 25 | -382.6% | 3.0% | ||
| Q1 25 | -933.1% | -18.8% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | -13.8% | ||
| Q2 24 | — | 16.8% | ||
| Q1 24 | -406.8% | -5.7% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | 20.8% | 0.7% | ||
| Q2 25 | 34.8% | 0.5% | ||
| Q1 25 | 91.8% | 0.0% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | 5.3% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
